Ardent Health, Inc.
For the period ended Jun 30, 2025. Filed Aug 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 6, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in thousands, except per share amounts)
| June 30, 2025 (1) | December 31, 2024 (1) | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $540,629 | $556,785 |
| Accounts receivable | 758,641 | 743,031 |
| Inventories | 118,403 | 115,093 |
| Prepaid expenses | 127,883 | 113,749 |
| Other current assets | 331,558 | 304,093 |
| Total current assets | 1,877,114 | 1,832,751 |
| Property and equipment, net | 870,377 | 861,899 |
| Operating lease right of use assets | 274,338 | 248,040 |
| Operating lease right of use assets, related party | 922,548 | 929,106 |
| Goodwill | 877,681 | 852,084 |
| Other intangible assets | 76,930 | 76,930 |
| Deferred income taxes | 17,072 | 12,321 |
| Other assets | 111,194 | 142,969 |
| Total assets | $5,027,254 | $4,956,100 |
| Liabilities and Equity | ||
| Current liabilities: | ||
| Current installments of long-term debt | $19,333 | $9,234 |
| Accounts payable | 364,450 | 401,249 |
| Accrued salaries and benefits | 259,160 | 295,117 |
| Other accrued expenses and liabilities | 237,930 | 239,824 |
| Total current liabilities | 880,873 | 945,424 |
| Long-term debt, less current installments | 1,090,390 | 1,085,818 |
| Long-term operating lease liability | 244,741 | 221,443 |
| Long-term operating lease liability, related party | 912,216 | 919,313 |
| Self-insured liabilities | 220,839 | 227,048 |
| Other long-term liabilities | 31,820 | 34,697 |
| Total liabilities | 3,380,879 | 3,433,743 |
| Commitments and contingencies (see Note 9) | ||
| Redeemable noncontrolling interests | (1,751) | 1,158 |
| Equity: | ||
| Preferred stock, par value $0.01 per share; 50,000,000 shares authorized; no shares issued and outstanding | — | — |
| Common stock, par value $0.01 per share; 750,000,000 shares authorized; 143,098,506 shares issued and outstanding as of June 30, 2025, and 142,747,818 shares issued and outstanding as of December 31, 2024 | 1,431 | 1,428 |
| Additional paid-in capital | 773,422 | 754,415 |
| Accumulated other comprehensive income (loss) | (396) | 9,737 |
| Retained earnings | 480,129 | 365,796 |
| Equity attributable to Ardent Health, Inc. | 1,254,586 | 1,131,376 |
| Noncontrolling interests | 393,540 | 389,823 |
| Total equity | 1,648,126 | 1,521,199 |
| Total liabilities and equity | $5,027,254 | $4,956,100 |
(1)As of June 30, 2025 and December 31, 2024, the unaudited condensed consolidated balance sheets included total liabilities of consolidated variable interest entities of$315.7
million and$306.4 million, respectively. Refer to Note 2, Summary of Significant Accounting Policies, for further discussion.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.